Table 1 Individual and cluster level characteristics of all study participants, stratified by Pfdhps and Pfcrt genotype
From: The changing landscape of Plasmodium falciparum drug resistance in the Democratic Republic of Congo
| Â | Pfdhps | Pfcrt | ||||
|---|---|---|---|---|---|---|
Wildtype (N = 81) | Any pfdhps mutation (N = 434) | P-value*** | Wildtype (N = 306) | CVIET haplotype (N = 369) | P-value*** | |
Malaria prevalence (SD) | 59.3 (20.4) | 58.9 (21.8) | 0.872 | 60.04 (21.74) | 57.42 (22.24) | 0.125 |
Anti-malarial use during pregnancya (SD) | 16.7 (16.6) | 22.2 (18.1) | 0.011 | 2.0 (6.2) | 1.9 (6.0) | 0.955 |
Anti-malarial use amongst children (SD)b | 3.0 (6.4) | 2.0 (5.6) | 0.126 | 1.7 (4.4) | 1.6 (4.0) | 0.745 |
Mean DHS Cluster size (SD) | 17.9 (18.0) | 19.3 (18.8) | 0.652 | 17.8 (19.07) | 20.0 (22.14) | 0.266 |
% without education (SD) | 32.7 (23.48) | 23.1 (21.5) | < 0.001 | 28.8 (24.41) | 22.0 (20.16) | < 0.001 |
% in lowest wealth category (SD) | 30.2 (23.0) | 21.4 (22.5) | 0.001 | 27.2 (22.5) | 20.5 (22.5) | < 0.001 |
Number living in urban area (%) | 28 (34.6) | 154 (35.4) | 0.975 | 90 (29.4) | 135 (36.6) | 0.059 |
Individual covariates: | ||||||
 Number female (%) | 41 (50.6) | 228 (52.5) | 0.845 | 153 (50.0) | 192 (52.0) | 0.654 |
 Median Individual Wealth Index (IQR) | 2 (1–3) | 3 (1–4) | 0.015 | 2 (1–3) | 3 (2–4) | < 0.001 |